Cpl Life Sciences US

US Staffing within Life Sciences

Close
  • Job Search
    • Physicians
    • Clinical Research
    • Regulatory Affairs
    • Send us your Resume
  • About Us
    • Meet The Team
    • Testimonials
    • Press
    • Contact Us
  • Industry Training
  • Client Services
    • Testimonials
  • Case Studies
  • My Account
Menu

Uncategorized

Written by Cpl Life Sciences US
February 7, 2020

The 10 most-anticipated drug launches of 2020

FiercePharma with assistance from EvaluatePharma, have assembled a list of the top 10 most-anticipated new drug launches of 2020 based on estimated global sales in 2024. Eight out of the ten could break the blockbuster barrier in four short year putting a new batch of heavy hitters in pharma’s ranks. First is AstraZeneca and Daiichi Sankyo’s breast

Continue Reading

Written by Cpl Life Sciences US
October 3, 2019

FDA gives approval JnJ new kidney disease

Johnson & Johnson’s Invokana has become the only drug in the SGLT2 inhibitor class to be approved by the FDA for treating diabetic kidney disease (DKD) and to reduce the risk of hospitalisation for heart failure in patients with type 2 diabetes and DKD. Based on results of the CREDENCE trial, J&J’s drug reduced the

Continue Reading

Written by Cpl Life Sciences US
September 6, 2019

Cancer drug approvals by FDA has doubled this decade thanks to smarter R&D

In the 1980s, only 4% of new drugs approved by the FDA were cancer treatments. But since 2010, cancer drugs have claimed 27% of new approvals—a share that doubled over the previous decade—according to a new report from the Tufts Center for the Study of Drug Development. It is believed that this is due to

Continue Reading

Written by Cpl Life Sciences US
July 12, 2019

Trump vows action on “Favoured nation” drug price clause

President Donald Trump is preparing an executive order outlining a “favoured nations clause”, where US prices will reflect those in the country paying the least for their medicines. Trump recently made the announcement in a press briefing outside the White House, more than two years after promises to tackle high drug prices had been a

Continue Reading

Categories

  • Career Advice
  • Company Info
  • Industry news
  • Uncategorized
  • News

Tags

Abbvie achillion acquisitions advertising Alexion Allergan AstraZeneca Biosimilar Biotech BMS Boston Breast Cancer Brexit clinical research Clinical Trial clinical trials CMO Conference CPL Physicians drug development Elections Eli Lilly FDA Gene therapy Gilead graduate academy Health Hep C immuno-oncology J&J JnJ Networking Novartis Novo Nordisk oncology Parexel Pfizer Pharmaceutical Regulatory Roche Sandoz Sanofi Takeda UK US

Like to Talk to a Consultant?

Call or email us directly and find out your next career step:
info@cplphysicians.com or (617) 844-1434



Part of the Cpl Group

Expert Life Science Staffing

Contact Us

Call or email us to find out how we can assist you today

Call Us

Email Us

Our Offices

HEADQUARTERS
Cambridge, Boston,
Call: (617) 844-1434

UK
T: +44 (0)118 9522 799
BELGIUM
T: +32 (0)2 892 3993
GERMANY
T: +49 (0)711 222 54 403
IRELAND
T: +353 (0)144 752 96

© 2017 CPL Physicians — All Rights Reserved
Linked In Twitter Google
Back to Top